Hisafumi Okabe

400 citations
11 papers · 237 indexed · h-index 6
Topics
Monoclonal and Polyclonal Antibodies Research (4 papers)Glycosylation and Glycoproteins Research (2 papers)Platelet Disorders and Treatments (2 papers)

In The Last Decade

Hisafumi Okabe

10 papers receiving 233 citations

Peers

Hisafumi Okabe
Comparison fields: 5 of 54
  • Oncology 125
  • Molecular Biology 98
  • Pulmonary and Respiratory Medicine 57
  • Pathology and Forensic Medicine 29
  • Surgery 23
Replace Mehrad Tavallai with:
Mehrad Tavallai United States
John Lenehan Canada
Shunji Kamazawa Japan
Emily Anderson United States
Christopher L. Seiler United States
María Jimena Rodriguez Spain
Victoria Ling Australia
Sitki Copur United States
J. Gardiner United Kingdom
Qianqian Deng China
Hisafumi Okabe relative to Mehrad Tavallai United States Mehrad Tavallai's profile →
Citations per field
00.5×1.6×
Mehrad Tavallai · 1×
Citations per year

Countries citing papers authored by Hisafumi Okabe

Since Specialization
Citations

This map shows the geographic impact of Hisafumi Okabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisafumi Okabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisafumi Okabe more than expected).

Fields of papers citing papers by Hisafumi Okabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisafumi Okabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisafumi Okabe. The network helps show where Hisafumi Okabe may publish in the future.

Co-authorship network of co-authors of Hisafumi Okabe

This figure shows the co-authorship network connecting the top 25 collaborators of Hisafumi Okabe. A scholar is included among the top collaborators of Hisafumi Okabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisafumi Okabe. Hisafumi Okabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 20
2 2
3 1
4 5
5 7
6 0
7 8
8 52
9 35
10
Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
106
11
[Clinical study of serum ErbB-2 protein using sandwich radioimmunometric assay (ErbB-2 IRMA 'Eiken')].
1

About Hisafumi Okabe

Hisafumi Okabe is a scholar working on Physiology, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 237 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Oncology (125 citations), Pulmonary and Respiratory Medicine (57 citations) and Pathology and Forensic Medicine (29 citations). Hisafumi Okabe has collaborated with scholars based in Japan, Switzerland and Australia. Frequent co-authors include Masaki Kitajima, Tetsuro Kubota, Koichiro Kumai, Tatsuo Teramoto, Teiji Takechi, Yoshiki Ishikawa, Masahiko Watanabe, Masakazu Fukushima, Masahiko Watanabe and Hironobu Nakayama. Their work appears in journals such as Blood, Cancer Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026